PGF is one of the drug targets for vascular endothelial growth factor (VEGF) inhibitors used to treat, for example, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy. This evidence concerns the gene VEGFA and retinal vein occlusion.